The Southeast's dominant supermarket chain announced Monday that it's included in last week's recall.

The FDA has approved intranasal etripamil (Cardamyst; Milestone Pharmaceuticals) for the acute treatment of paroxysmal supraventricular tachycardia (PSVT), making it the first self-administered, ...

The U.S. Food and Drug Administration has announced a nationwide recall of nasal spray, which officials report has been found ...

Federal health officials say all lots of a nasal spray product distributed nationwide is being recalled due to microbial ...

Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...